Your shopping cart is currently empty

MAO-B-IN-28 (compound 10e) is a potent hMAO-B inhibitor with an IC50 value of 1.9±0.5 nM, potentially serving as a candidate molecule for neurodegenerative disease research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | MAO-B-IN-28 (compound 10e) is a potent hMAO-B inhibitor with an IC50 value of 1.9±0.5 nM, potentially serving as a candidate molecule for neurodegenerative disease research. |
| In vitro | MAO-B-IN-28 (0.5-128 μM, 24 h) exhibits significant cytotoxicity against MCF-7 cells, while it shows no notable cytotoxic effects on MGC-803, HCT-116, or HepG2 cells. Additionally, MAO-B-IN-28 (0.5, 4 μM, 24 h) demonstrates no cytotoxicity to differentiated SH-SY5Y cells and HVSMC cells. Furthermore, MAO-B-IN-28 (2, 4 μM, 24 h) does not increase ROS levels or cause oxidative damage in differentiated SH-SY5Y cells. |
| Molecular Weight | 405.35 |
| Formula | C19H10F3NO4S |
| Cas No. | 3028096-72-9 |
| Smiles | O=C1C=2C=CC=CC2S(=O)(=O)C=C1C=3ON=C(C3)C=4C=CC=C(C4)C(F)(F)F |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.